vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Revolve Group, Inc. is the larger business by last-quarter revenue ($324.4M vs $284.0M, roughly 1.1× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 5.7%, a 90.6% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 9.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
ACAD vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $284.0M | $324.4M |
| Net Profit | $273.6M | $18.6M |
| Gross Margin | 90.8% | 53.3% |
| Operating Margin | 6.1% | 6.3% |
| Net Margin | 96.3% | 5.7% |
| Revenue YoY | 9.4% | 10.4% |
| Net Profit YoY | 90.3% | 50.4% |
| EPS (diluted) | $1.61 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $324.4M | ||
| Q3 25 | $278.6M | $295.6M | ||
| Q2 25 | $264.6M | $309.0M | ||
| Q1 25 | $244.3M | $296.7M | ||
| Q4 24 | $259.6M | $293.7M | ||
| Q3 24 | $250.4M | $283.1M | ||
| Q2 24 | $242.0M | $282.5M | ||
| Q1 24 | $205.8M | $270.6M |
| Q4 25 | $273.6M | $18.6M | ||
| Q3 25 | $71.8M | $21.2M | ||
| Q2 25 | $26.7M | $10.2M | ||
| Q1 25 | $19.0M | $11.8M | ||
| Q4 24 | $143.7M | $12.3M | ||
| Q3 24 | $32.8M | $11.0M | ||
| Q2 24 | $33.4M | $15.4M | ||
| Q1 24 | $16.6M | $10.9M |
| Q4 25 | 90.8% | 53.3% | ||
| Q3 25 | 92.2% | 54.6% | ||
| Q2 25 | 92.2% | 54.1% | ||
| Q1 25 | 91.7% | 52.0% | ||
| Q4 24 | 91.6% | 52.5% | ||
| Q3 24 | 92.5% | 51.2% | ||
| Q2 24 | 92.5% | 54.0% | ||
| Q1 24 | 88.8% | 52.3% |
| Q4 25 | 6.1% | 6.3% | ||
| Q3 25 | 12.8% | 7.1% | ||
| Q2 25 | 12.2% | 5.8% | ||
| Q1 25 | 7.9% | 5.0% | ||
| Q4 24 | 59.1% | 3.9% | ||
| Q3 24 | 12.6% | 5.0% | ||
| Q2 24 | 12.6% | 5.8% | ||
| Q1 24 | 7.4% | 3.4% |
| Q4 25 | 96.3% | 5.7% | ||
| Q3 25 | 25.8% | 7.2% | ||
| Q2 25 | 10.1% | 3.3% | ||
| Q1 25 | 7.8% | 4.0% | ||
| Q4 24 | 55.4% | 4.2% | ||
| Q3 24 | 13.1% | 3.9% | ||
| Q2 24 | 13.8% | 5.4% | ||
| Q1 24 | 8.0% | 4.0% |
| Q4 25 | $1.61 | $0.27 | ||
| Q3 25 | $0.42 | $0.29 | ||
| Q2 25 | $0.16 | $0.14 | ||
| Q1 25 | $0.11 | $0.16 | ||
| Q4 24 | $0.86 | $0.18 | ||
| Q3 24 | $0.20 | $0.15 | ||
| Q2 24 | $0.20 | $0.21 | ||
| Q1 24 | $0.10 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $292.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $512.5M |
| Total Assets | $1.6B | $765.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $292.3M | ||
| Q3 25 | $258.0M | $315.4M | ||
| Q2 25 | $253.6M | $310.7M | ||
| Q1 25 | $217.7M | $300.8M | ||
| Q4 24 | $319.6M | $256.6M | ||
| Q3 24 | $155.1M | $252.8M | ||
| Q2 24 | $177.1M | $244.7M | ||
| Q1 24 | $204.7M | $273.4M |
| Q4 25 | $1.2B | $512.5M | ||
| Q3 25 | $917.3M | $490.2M | ||
| Q2 25 | $822.4M | $468.6M | ||
| Q1 25 | $765.2M | $453.4M | ||
| Q4 24 | $732.8M | $437.8M | ||
| Q3 24 | $577.2M | $420.8M | ||
| Q2 24 | $516.7M | $405.8M | ||
| Q1 24 | $464.0M | $389.9M |
| Q4 25 | $1.6B | $765.0M | ||
| Q3 25 | $1.3B | $751.3M | ||
| Q2 25 | $1.2B | $722.9M | ||
| Q1 25 | $1.1B | $713.9M | ||
| Q4 24 | $1.2B | $665.5M | ||
| Q3 24 | $976.9M | $670.9M | ||
| Q2 24 | $914.1M | $657.8M | ||
| Q1 24 | $855.1M | $650.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-10.2M |
| Free Cash FlowOCF − Capex | — | $-13.3M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | -0.18× | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-10.2M | ||
| Q3 25 | $74.3M | $11.8M | ||
| Q2 25 | $64.0M | $12.6M | ||
| Q1 25 | $20.3M | $45.1M | ||
| Q4 24 | $40.4M | $3.9M | ||
| Q3 24 | $63.2M | $9.1M | ||
| Q2 24 | $25.0M | $-24.7M | ||
| Q1 24 | $29.1M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | $73.9M | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $63.2M | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | 26.5% | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | 25.2% | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | -0.18× | -0.55× | ||
| Q3 25 | 1.03× | 0.56× | ||
| Q2 25 | 2.40× | 1.24× | ||
| Q1 25 | 1.07× | 3.82× | ||
| Q4 24 | 0.28× | 0.32× | ||
| Q3 24 | 1.93× | 0.83× | ||
| Q2 24 | 0.75× | -1.60× | ||
| Q1 24 | 1.76× | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |